CiB (Centro de Informação de Biotecnologia) welcomes the call of the European Commission for Evidence on the implementing framework for Category 2 NGT plants under Regulation (EU) 2026/1388. CiB considers that Category2 NGT plants require a regulatory framework specifically designed for new genomic techniques and not one derived from the existing EU regulatory approach for classical genetically modified organisms.
CIO
Centro de Informação de Biotecnologia
NGO · Portugal
not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts (staff, costs, accreditations) are not available for it.
2
positions filed
in the 655 files tracked
1
legislative file
of 655 tracked
2
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 655 consultation files tracked so far (56,999 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Track Centro in PolicySpeak: request access →
Work at Centro de Informação de Biotecnologia? so we know who speaks for it.
Their record over time
Centro de Informação de Biotecnologia filed 2 positions on 25 Sept 2026, across 1 of the 655 legislative files tracked here, attaching a full position paper 2 times.
What they argued
CIB welcomes the call of the European Commission for Evidence on the implementation of the verification system for Category 1 NGT plants under Regulation (EU) 2026/1388. CIB considers that the success of the new framework will depend on a verification procedure that is scientifically sound, proportionate, predictable and workable.
Filed in Portuguese · English published by the European Commission
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Centro de Informação de Biotecnologia next to another organization. Same files, same register facts, side by side. Compare →
Is this your organization?
Everything on this page comes from Centro de Informação de Biotecnologia’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.